SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004267
Filing Date
2021-11-12
Accepted
2021-11-12 08:24:50
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cmpx-20210930.htm   iXBRL 10-Q 2110096
2 EX-31.1 cmpx-ex31_1.htm EX-31.1 16985
3 EX-31.2 cmpx-ex31_2.htm EX-31.2 17313
4 EX-32.1 cmpx-ex32_1.htm EX-32.1 9947
5 EX-32.2 cmpx-ex32_2.htm EX-32.2 9970
6 EX-99.1 cmpx-ex99_1.htm EX-99.1 224280
7 GRAPHIC img118687774_0.jpg GRAPHIC 58064
8 GRAPHIC img174977587_0.jpg GRAPHIC 4234
  Complete submission text file 0000950170-21-004267.txt   7187806

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmpx-20210930_def.xml EX-101.DEF 162782
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmpx-20210930_lab.xml EX-101.LAB 397862
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmpx-20210930.xsd EX-101.SCH 46104
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmpx-20210930_cal.xml EX-101.CAL 44797
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmpx-20210930_pre.xml EX-101.PRE 285635
14 EXTRACTED XBRL INSTANCE DOCUMENT cmpx-20210930_htm.xml XML 1060124
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39696 | Film No.: 211399887
SIC: 2836 Biological Products, (No Diagnostic Substances)